Quick Answer
Edesa Biotech, Inc. reported Total Assets of $13.53 million for the year ending 2025.
- Edesa Biotech, Inc. showed an increase of +254.8% in Total Assets from 2024 to 2025.
- This data is from Edesa Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on December 12, 2025.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $16.07 million | Q4 2014: $13.43 million | Q1 2015: $11.83 million | Q2 2015: $11.21 million | Q4 2015: $10.35 million | Q1 2016: $9.43 million | Q2 2016: $8.50 million | Q4 2016: $11.47 million | Q1 2017: $10.22 million | Q2 2017: $9.02 million | Q4 2017: $6.59 million | Q1 2018: $5.33 million | Q2 2018: $12.80 million | Q3 2018: $11.78 million | Q4 2018: $3.40 million | Q1 2019: $9.15 million | Q2 2019: $7.23 million | Q4 2019: $5.09 million | Q1 2020: $7.63 million | Q2 2020: $8.92 million | Q4 2020: $10.29 million | Q1 2021: $24.00 million | Q2 2021: $16.88 million | Q4 2021: $12.34 million | Q1 2022: $20.41 million | Q2 2022: $17.54 million | Q4 2022: $11.67 million | Q1 2023: $10.67 million | Q2 2023: $9.42 million | Q4 2023: $7.83 million | Q1 2024: $6.48 million | Q2 2024: $5.23 million | Q4 2024: $4.16 million | Q1 2025: $16.45 million | Q2 2025: $14.80 million | Q3 2025: $13.53 million | Q4 2025: $14.71 million.
- Over the full 13 years of available data (2014 to 2025), Edesa Biotech, Inc.'s Total Assets has declined by 6.5%.
- Historical annual values: Fiscal year 2025: $13.53 million | Fiscal year 2024: $3.81 million | Fiscal year 2023: $8.89 million | Fiscal year 2022: $11.58 million | Fiscal year 2021: $14.58 million | Fiscal year 2020: $10.76 million | Fiscal year 2019: $5.72 million | Fiscal year 2018: $11.78 million | Fiscal year 2017: $7.72 million | Fiscal year 2016: $12.94 million | Fiscal year 2015: $10.39 million | Fiscal year 2014: $14.83 million | Fiscal year 2014: $14.47 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: